|
ANKRD44 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.100460E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.395200E-03 |
| Normal-vs-Stage2 |
5.66610000000134E-05 |
| Normal-vs-Stage3 |
6.605000E-04 |
| Normal-vs-Stage4 |
2.575600E-03 |
| Stage1-vs-Stage2 |
1.380590E-03 |
| Stage1-vs-Stage3 |
1.340590E-01 |
| Stage1-vs-Stage4 |
4.647400E-01 |
| Stage2-vs-Stage3 |
1.186990E-01 |
| Stage2-vs-Stage4 |
1.285370E-01 |
| Stage3-vs-Stage4 |
7.283200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.541400E-03 |
| Normal-vs-AfricanAmerican |
2.423600E-02 |
| Normal-vs-Asian |
8.758700E-03 |
| Caucasian-vs-AfricanAmerican |
5.635000E-01 |
| Caucasian-vs-Asian |
5.724800E-01 |
| AfricanAmerican-vs-Asian |
8.951800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.077810E-03 |
| Normal-vs-Female |
1.325000E-03 |
| Male-vs-Female |
6.160800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.563500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.750300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.818300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.678800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.151870E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.597830E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.593000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.851800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.410200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.913200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.734600E-01 |
| Classical-VS-Follicular |
4.24399999999769E-05 |
| Classical-VS-Other |
8.958000E-02 |
| Classical-VS-Normal |
4.580400E-03 |
| Tall-VS-Follicular |
3.541200E-01 |
| Tall-VS-Other |
1.479950E-01 |
| Tall-VS-Normal |
2.860900E-03 |
| Follicular-VS-Other |
4.395000E-01 |
| Follicular-VS-Normal |
4.49570000000676E-05 |
| Other-VS-Normal |
8.3445999999987E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.605600E-04 |
| Normal-vs-N1 |
5.554400E-04 |
| N0-vs-N1 |
8.814000E-01 |
|
|
